Centogene Correlations
CNTG Stock | USD 0.09 0.01 16.88% |
The current 90-days correlation between Centogene B V and Fonar is 0.05 (i.e., Significant diversification). The correlation of Centogene is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Centogene Correlation With Market
Significant diversification
The correlation between Centogene B V and DJI is 0.02 (i.e., Significant diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Centogene B V and DJI in the same portfolio, assuming nothing else is changed.
Centogene |
Moving against Centogene Stock
0.57 | DXCM | DexCom Inc | PairCorr |
0.49 | VREX | Varex Imaging Corp | PairCorr |
0.46 | EW | Edwards Lifesciences Corp | PairCorr |
0.44 | GH | Guardant Health | PairCorr |
0.44 | LH | Laboratory | PairCorr |
0.38 | VEEV | Veeva Systems Class Earnings Call This Week | PairCorr |
0.37 | ENOV | Enovis Corp | PairCorr |
0.36 | MD | Mednax Inc | PairCorr |
0.32 | ECOR | Electrocore LLC | PairCorr |
0.62 | COR | Cencora | PairCorr |
0.48 | ABT | Abbott Laboratories Fiscal Year End 22nd of January 2025 | PairCorr |
0.48 | XAIR | Beyond Air | PairCorr |
0.48 | CAH | Cardinal Health | PairCorr |
0.43 | DGX | Quest Diagnostics | PairCorr |
0.34 | BSX | Boston Scientific Corp | PairCorr |
0.33 | FOXO | FOXO Technologies | PairCorr |
Related Correlations Analysis
Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Centogene Stock performing well and Centogene Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Centogene's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
---|---|---|---|---|---|---|---|---|---|---|
GTH | 1.87 | 0.03 | (0.03) | (0.30) | 2.49 | 3.45 | 14.43 | |||
FONR | 1.49 | (0.15) | 0.00 | (0.10) | 0.00 | 2.15 | 10.60 | |||
XGN | 3.75 | 0.37 | 0.10 | 0.48 | 3.42 | 9.62 | 25.65 | |||
SERA | 3.84 | (0.36) | 0.00 | (0.01) | 0.00 | 9.55 | 27.67 | |||
SHC | 1.77 | (0.41) | 0.00 | (0.18) | 0.00 | 3.74 | 13.40 | |||
OLK | 0.63 | 0.13 | 0.07 | 0.50 | 0.48 | 1.58 | 4.37 | |||
MDXH | 2.30 | (0.63) | 0.00 | (0.72) | 0.00 | 3.74 | 24.02 | |||
NOTV | 5.34 | 1.08 | 0.31 | 0.35 | 4.12 | 14.07 | 42.16 | |||
STRRP | 1.08 | (0.08) | 0.00 | (0.60) | 0.00 | 2.21 | 14.03 | |||
LMDX | 4.74 | (0.96) | 0.00 | (0.64) | 0.00 | 11.54 | 34.05 |
Centogene Corporate Management
Ian Rentsch | Chief Pharma | Profile | |
Peter MD | Chief Officer | Profile | |
Andrin MD | Advisor | Profile | |
Kim Stratton | CEO Board | Profile | |
Bettina Goerner | Chief Officer | Profile | |
Lennart Streibel | Director Projects | Profile | |
Florian Vogel | Chief Officer | Profile |